RAD Company Financials

RAD 
$2.82
*  
0.07
  negative  
2.42%
Get RAD Alerts
*Delayed - data as of May 22, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    RAD Pre-Market
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Quarterly Income Statement (values in 000's)

Quarter: Trend 4th 3rd 2nd 1st
Quarter Ending: 3/2/2013 12/1/2012 9/1/2012 6/2/2012
Total Revenue
$6,455,245 $6,237,847 $6,230,884 $6,468,287
Cost of Revenue
$4,407,482 $4,426,526 $4,520,463 $4,719,516
Gross Profit
$2,047,763 $1,811,321 $1,710,421 $1,748,771
Operating Expenses
Research and Development
$0 $0 $0 $0
Sales, General and Admin.
$1,682,332 $1,612,198 $1,618,169 $1,688,066
Non-Recurring Items
$36,567 $14,366 $7,783 $12,143
Other Operating Items
$0 $0 $0 $0
Operating Income
$328,864 $184,757 $84,469 $48,562
Add'l income/expense items
($125,151) $6,262 $2,954 ($7,791)
Earnings Before Interest and Tax
$203,713 $191,019 $87,423 $40,771
Interest Expense
$127,408 $128,371 $129,054 $130,588
Earnings Before Tax
$76,305 $62,648 ($41,631) ($89,817)
Income Tax
($46,782) $777 ($2,866) ($61,729)
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
$123,087 $61,871 ($38,765) ($28,088)
Net Income
$123,087 $61,871 ($38,765) ($28,088)
Net Income Applicable to Common Shareholders
$120,371 $59,194 ($41,403) ($30,687)

See also: Company Financials data entry page